Myoma;Uterus Clinical Trial
Official title:
Prevalence of Intrauterine Adhesions After Abdominal Myomectomy
NCT number | NCT04030273 |
Other study ID # | ADAM-1 |
Secondary ID | |
Status | Not yet recruiting |
Phase | |
First received | |
Last updated | |
Start date | January 2022 |
Est. completion date | January 2024 |
Uterine fibroids are the most common benign tumors of the genital organs of women of childbearing age. Literature data show that more than 75% of women have fibroids.Symptomatic fibroids account for approximately over 200,000 hysterectomies and 50,000 myomectomies annually in the United States. Fibroids have a major impact on fertility, with significant adverse effect on implantation rate and spontaneous abortion rates when compared with infertile women without fibroids. The definitive treatment for uterine fibroids in a fertile patient is surgical excision. Although usually effective, myomectomy is not a risk-free operation, since the surgical procedure can cause mechanical infertility and can be associated with infection, injury to adjacent tissues, hemorrhage and need to convert to hysterectomy. A not often mentioned consequence of myomectomy is post-operative intrauterine adhesion formation. It has been reported that 50% of women undergoing open myomectomy are found to have intrauterine adhesions diagnosed by hysteroscopy performed 3 months after surgery. Such a high prevalence of intrauterine adhesions after open myomectomy is unexpected, however only few studies have addressed this topic. It is accepted that injury to the endometrium is generally considered to be the primary causative factor for the development of intrauterine adhesions. The reason for such a high incidence of intrauterine adhesions after open myomectomy is unclear. It is speculated that infection or in adverted closure of the uterine cavity may play a role in intrauterine adhesion formation. The relationship between the number of fibroids removed and the risk of adhesions suggests a traumatic etiology. In the preservation of the uterus for the purpose of fertility, it is essential to also understand the impact of myomectomy on the endometrium. Currently no guideline recommends in office hysteroscopy as follow-up after myomectomy. The purpose of the present study is to evaluate the frequency of uterine adhesions following myomectomy and the impact of number, size and location of the fibroids as well as intraoperative breach of the endometrial cavity at the time of the myomectomy.
Status | Not yet recruiting |
Enrollment | 150 |
Est. completion date | January 2024 |
Est. primary completion date | January 2023 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - Diagnosis of one or more uterine myomas - Desire to preserve fertility/uterus - Myomectomy (by laparotomy, laparoscopy or robotic approach). Exclusion Criteria: - Adults unable to consent - Pregnant women - Prisoners - History of previous intrauterine procedures such as dilation and curettage - History of known intrauterine adhesions - History of documented pelvic inflammatory disease - History of endometritis (acute or chronic) - Hysteroscopic myomectomy |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Università degli Studi dell'Insubria | University of Miami |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Intrauterine adhesions | Presence of intrauterine adhesion, following the American Fertility Society classification (Fertil Steril. 1988;49:944-955.) in mild, moderate, or severe. | 3 months after myomectomy |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04519593 -
ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma
|
N/A | |
Active, not recruiting |
NCT06114758 -
Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in Myomectomy
|
||
Not yet recruiting |
NCT05967936 -
Paracervical Block Versus Transcervical Block in Outpatient Procedural Hysteroscopy
|
N/A | |
Not yet recruiting |
NCT05932082 -
The Impact of Myomectomy on IVF Outcomes
|
N/A | |
Recruiting |
NCT04748978 -
OPPIuM Technique and Myolysis With Diode Laser Dwls
|
N/A | |
Recruiting |
NCT05271981 -
Fertility After Uterine Artery Embolization
|
||
Completed |
NCT05025410 -
Remimazolam and Remifentanil Without Neuromuscular Blocking Agent
|
||
Recruiting |
NCT03483142 -
the Effect of Misoprostol on Intra-operative Blood Loss During Myomectomy Operation
|
Phase 3 | |
Completed |
NCT03533907 -
Pregnancy Outcomes in Infertile Patients After Treatment With Ulipristal Acetate.
|
||
Completed |
NCT05811286 -
The Use of a Morcellator in Operative Hysteroscopy for Benign Intracavitary Lesions: a Feasibility Study
|
N/A | |
Not yet recruiting |
NCT03570879 -
Laparoscopic Myomectomy With Morcellation or Transvaginal Extraction of Surgical Specimens.
|
||
Not yet recruiting |
NCT04364581 -
Endometrial Preparation by Short Course of Letrozole Before Hysteroscopic Removal of Endocavitary Lesions
|
Phase 4 | |
Recruiting |
NCT06067971 -
Evaluation of the Feasibility of Using Augmented Reality in Laparoscopic Surgery, by a Clinical Study During Gynecological Laparoscopic Surgical Procedures. (ENDORA2)
|
N/A | |
Recruiting |
NCT04990076 -
Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology
|
||
Recruiting |
NCT06325501 -
Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy
|
Phase 3 | |
Completed |
NCT05761418 -
Preoperative Vaginal Dinoprostone Versus Misoprostone in Abdominal Myomectomy
|
Phase 3 | |
Recruiting |
NCT04311073 -
Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies
|
Phase 3 | |
Active, not recruiting |
NCT05930769 -
Retrospective Study on the Evaluation of the Impact of Augmented Reality Usage in Gynecological Laparoscopy on Patients Operated Between 2017 and 2021 (ImpactRA)
|
||
Recruiting |
NCT03550703 -
Open Label Immunotherapy of Myoma
|
Phase 2 | |
Completed |
NCT04482959 -
Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic Myomectomy
|
Phase 4 |